| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 15 | |
| #2 | Australia | 11 | |
| #3 | EPO (European Patent Office) | 10 | |
| #4 | WIPO (World Intellectual Property Organization) | 5 | |
| #5 | China | 3 | |
| #6 | Republic of Korea | 3 | |
| #7 | Canada | 2 | |
| #8 | Brazil | 1 | |
| #9 | Chile | 1 | |
| #10 | Hong Kong | 1 | |
| #11 | Tunisia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Basic materials chemistry | |
| #5 | Environmental technology | |
| #6 | Measurement | |
| #7 | Medical technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Schultz Peter G | 50 |
| #2 | Wang Feng | 17 |
| #3 | Young Travis | 16 |
| #4 | Chatterjee Arnab K | 13 |
| #5 | Shen Weijun | 13 |
| #6 | Liu Yan | 12 |
| #7 | Yang Pengyu | 10 |
| #8 | Kim Chanhyuk | 9 |
| #9 | Yang Baiyuan | 9 |
| #10 | Tremblay Matthew S | 8 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018067465A1 | Compositions and methods for treating drug-resistant bacteria | |
| WO2018013483A1 | Kv1.3 channel blocking peptides and uses thereof | |
| EP3411069A2 | Humanized anti-cd3 antibodies, conjugates and uses thereof | |
| EP3387019A2 | Relaxin immunoglobulin fusion proteins and methods of use | |
| AU2016315889A1 | Insulin immunoglobulin fusion proteins | |
| EP3310376A1 | Modified therapeutic agents and compositions thereof | |
| US2017327577A1 | Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof |